ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
SPDR Spyder Cannabis Inc
- 0.000
- 0.0000.00%
15min DelayMarket Closed Dec 13 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.21552wk High0.00%Turnover Ratio14.81MShares0.17052wk Low-0.14EPS TTM0Float Cap1.950Historical High0.00P/E (Static)4.43MShs Float0.075Historical Low-0.15EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Spyder Cannabis Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jul 31, 2021 | (Q1)Apr 30, 2021 | (FY)Jan 31, 2021 | (Q4)Jan 31, 2021 | (Q3)Oct 31, 2020 | (Q2)Jul 31, 2020 | (Q1)Apr 30, 2020 | (FY)Jan 31, 2020 | (Q4)Jan 31, 2020 | (Q3)Oct 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 281.18%209.68K | -49.58%-202.51K | 59.42%-316.26K | 34.87%-98.2K | 116.87%33.05K | -115.73K | -1,943.22%-135.38K | -779.39K | -150.77K | -5,146.72%-195.97K |
| Net income from continuing operations | -105.19%-801.28K | 37.14%-217.47K | 39.90%-1.31M | 68.34%-397.42K | 31.19%-175.72K | ---390.51K | -5,121.55%-345.98K | ---2.18M | ---1.26M | -6,736.73%-255.35K |
| Depreciation and amortization | 505.77%362.25K | 15.81%149.29K | 29.05%242.11K | -127.49%-10.64K | 18.68%64.05K | --59.8K | --128.91K | --187.62K | --38.71K | --53.97K |
| Asset impairment expenditure | ---- | ---- | --330.04K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non cashItems | 697.10%206.45K | 218.82%82.94K | -106.63%-65.92K | -115.82%-142.96K | 78.33%25.13K | --25.9K | --26.01K | --994.47K | --903.61K | --14.09K |
| Change In working capital | 53.56%290.34K | -490.25%-217.27K | 123.77%487.13K | -24.36%122.78K | 1,479.43%119.6K | --189.08K | --55.68K | --217.69K | --162.33K | ---8.67K |
| -Change in receivables | -696.70%-79.93K | 247.39%52.38K | 3,294.27%41.78K | --0 | 14.60%13.31K | --13.4K | --15.08K | ---1.31K | --11.2K | --11.61K |
| -Change in inventory | 518.43%91.59K | -376.86%-65.17K | -643.28%-19.46K | 32.73%20.77K | -247.02%-41.87K | ---21.89K | --23.54K | --3.58K | --15.65K | ---12.07K |
| -Change in prepaid assets | -40.72%22.33K | 77.21%-47.68K | -74.70%23.8K | 43.89%-22.94K | 5,688.71%218.3K | --37.67K | ---209.23K | --94.09K | ---40.88K | ---3.91K |
| -Change in payables and accrued expense | 39.52%223.09K | -171.91%-162.72K | 263.48%441K | -29.15%124.95K | -1,527.22%-70.13K | --159.9K | --226.28K | --121.33K | --176.36K | ---4.31K |
| -Change in other working capital | --33.26K | --5.92K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 281.18%209.68K | -49.58%-202.51K | 59.42%-316.26K | 34.87%-98.2K | 116.87%33.05K | ---115.73K | -1,943.22%-135.38K | ---779.39K | ---150.77K | -5,146.72%-195.97K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -206.03%-233.64K | -100.32%-2.29K | -23,643.30%-185.91K | -20.56K | -24.89K | 220.36K | 709.67K | -783 | ||
| Net PPE purchase and sale | ---- | ---- | -22.45%-233.64K | -101.33%-9.29K | -22,749.30%-178.91K | ---20.56K | ---24.89K | ---190.81K | --698.51K | ---783 |
| Net investment purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --400K | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.17K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | -206.03%-233.64K | -100.32%-2.29K | -23,643.30%-185.91K | ---20.56K | ---24.89K | --220.36K | --709.67K | ---783 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -301.58%-451.94K | 1,312.79%918.48K | 18.94%720.18K | 172.37%320.68K | 322.32%110.28K | 224.2K | 65.01K | 605.48K | -443.14K | -49.61K |
| Net issuance payments of debt | -263.03%-351.94K | -499.85%-259.95K | 18.94%720.18K | 175.96%329.01K | 322.32%110.28K | --215.87K | --65.01K | --605.48K | ---433.14K | ---49.61K |
| Net common stock issuance | --0 | --960.89K | ---- | ---- | --0 | --8.33K | --0 | ---- | ---- | --0 |
| Proceeds from stock option exercised by employees | --100K | --17.55K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | --200K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -301.58%-451.94K | 1,312.79%918.48K | 18.94%720.18K | 172.37%320.68K | 322.32%110.28K | --224.2K | --65.01K | --605.48K | ---443.14K | ---49.61K |
| Net cash flow | ||||||||||
| Beginning cash position | 2,999.81%1.01M | 133.05%298.26K | 56.97%127.98K | 137.50%78.06K | -56.80%120.63K | --32.72K | 337.79%127.98K | --81.53K | --32.87K | 702.21%279.22K |
| Current changes in cash | -393.62%-258.12K | 851.59%715.97K | 266.59%170.28K | 90.22%220.2K | 82.72%-42.58K | --87.91K | -1,337.68%-95.26K | --46.45K | --115.76K | -6,495.80%-246.35K |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| End cash Position | 526.80%756.11K | 2,999.81%1.01M | 133.05%298.26K | 133.05%298.26K | 137.50%78.06K | --120.63K | 44.73%32.72K | --127.98K | --127.98K | 5.77%32.87K |
| Free cash from | 232.95%181.19K | -26.35%-202.51K | 43.32%-549.9K | -118.35%-100.48K | 22.31%-152.86K | ---136.29K | -2,318.85%-160.27K | ---970.2K | --547.74K | -5,167.68%-196.75K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.